Fabrication of Kidney Proximal Tubule Grafts Using Biofunctionalized Electrospun Polymer Scaffolds.


Journal

Macromolecular bioscience
ISSN: 1616-5195
Titre abrégé: Macromol Biosci
Pays: Germany
ID NLM: 101135941

Informations de publication

Date de publication:
02 2019
Historique:
received: 25 10 2018
pubmed: 15 12 2018
medline: 27 11 2019
entrez: 15 12 2018
Statut: ppublish

Résumé

The increasing prevalence of end-stage renal disease and persistent shortage of donor organs call for alternative therapies for kidney patients. Dialysis remains an inferior treatment as clearance of large and protein-bound waste products depends on active tubular secretion. Biofabricated tissues could make a valuable contribution, but kidneys are highly intricate and multifunctional organs. Depending on the therapeutic objective, suitable cell sources and scaffolds must be selected. This study provides a proof-of-concept for stand-alone kidney tubule grafts with suitable mechanical properties for future implantation purposes. Porous tubular nanofiber scaffolds are fabricated by electrospinning 12%, 16%, and 20% poly-ε-caprolactone (PCL) v/w (chloroform and dimethylformamide, 1:3) around 0.7 mm needle templates. The resulting scaffolds consist of 92%, 69%, and 54% nanofibers compared to microfibers, respectively. After biofunctionalization with L-3,4-dihydroxyphenylalanine and collagen IV, 10 × 10

Identifiants

pubmed: 30548802
doi: 10.1002/mabi.201800412
pmc: PMC7116029
mid: EMS94321
doi:

Substances chimiques

Biocompatible Materials 0
Caproates 0
Lactones 0
Polymers 0
caprolactone 56RE988L1R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1800412

Subventions

Organisme : European Research Council
ID : 647426
Pays : International
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : 022.006.003
Pays : International
Organisme : FP7 Ideas: European Research Council
ID : 647426
Pays : International
Organisme : University Medical Center Utrecht-Technical University Eindhoven
Pays : International

Informations de copyright

© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

Colloids Surf B Biointerfaces. 2011 Feb 1;82(2):307-15
pubmed: 20888196
Tissue Eng Part A. 2014 Jan;20(1-2):79-91
pubmed: 23902162
Tissue Eng Part A. 2018 May;24(9-10):830-848
pubmed: 29048241
Postgrad Med J. 2009 Feb;85(1000):91-101
pubmed: 19329704
Int J Nanomedicine. 2013;8:2131-9
pubmed: 23776333
Biomaterials. 2009 Jul;30(21):3523-31
pubmed: 19328545
Sci Rep. 2015 Nov 16;5:16702
pubmed: 26567716
Nat Commun. 2015 Apr 28;6:6933
pubmed: 25917746
Kidney Int. 2016 Sep;90(3):627-37
pubmed: 27521113
Eur J Pharmacol. 2016 Nov 5;790:28-35
pubmed: 27395800
Adv Healthc Mater. 2017 Jun;6(11):
pubmed: 28306221
Sci Rep. 2016 Oct 11;6:34845
pubmed: 27725720
Expert Opin Biol Ther. 2015 Apr;15(4):547-58
pubmed: 25640286
Int J Nanomedicine. 2018 Aug 03;13:4473-4492
pubmed: 30122921
Front Biosci (Elite Ed). 2015 Jan 01;7(2):215-28
pubmed: 25553375
Acta Biomater. 2013 Mar;9(3):5502-10
pubmed: 23201017
Cell Tissue Res. 2010 Feb;339(2):449-57
pubmed: 19902259
Acta Biomater. 2015 Mar;14:22-32
pubmed: 25527093
Bone Res. 2015 Jun 09;3:15012
pubmed: 26273539
AAPS J. 2018 Jul 26;20(5):87
pubmed: 30051196
Semin Nephrol. 2014 Mar;34(2):191-208
pubmed: 24780473
Biotechnol Adv. 2014 Nov 15;32(7):1317-1327
pubmed: 25135479
J Biomed Mater Res A. 2006 Oct;79(1):36-46
pubmed: 16758450
Adv Healthc Mater. 2018 Oct;7(19):e1800529
pubmed: 30091856
Curr Top Membr. 2015;76:231-53
pubmed: 26610916
J Tissue Eng Regen Med. 2017 Nov;11(11):3048-3055
pubmed: 27860413
PLoS One. 2016 Jul 28;11(7):e0158555
pubmed: 27467821
Adv Healthc Mater. 2017 Sep;6(18):
pubmed: 28699224
ACS Appl Mater Interfaces. 2015 Sep 9;7(35):19789-97
pubmed: 26280545
Curr Pharm Des. 2017;23(26):3845-3857
pubmed: 28699526
Curr Drug Targets. 2009 Dec;10(12):1227-34
pubmed: 19715535
Nat Cell Biol. 2016 Dec;18(12):1269-1280
pubmed: 27820600
J Nanosci Nanotechnol. 2013 Feb;13(2):1578-82
pubmed: 23646685
J Am Soc Nephrol. 2008 May;19(5):1034-40
pubmed: 18272842
J Biomed Mater Res B Appl Biomater. 2009 Aug;90(2):668-78
pubmed: 19213048
Biomaterials. 2011 Feb;32(6):1465-76
pubmed: 21145586
AAPS J. 2016 Mar;18(2):465-75
pubmed: 26821801
PLoS One. 2015 Aug 05;10(8):e0132482
pubmed: 26244978
J Vis Exp. 2017 Dec 23;(130):
pubmed: 29364204
Expert Rev Med Devices. 2018 May;15(5):323-336
pubmed: 29633900
J Tissue Eng Regen Med. 2012 Nov;6(10):786-92
pubmed: 22052853

Auteurs

Katja Jansen (K)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99,, 3584, CG Utrecht, The Netherlands.

Miguel Castilho (M)

Department of Orthopaedics, University Medical Center Utrecht, Utrecht University, P.O. Box 85500,, 3508, GA Utrecht, The Netherlands.
Regenerative Medicine Center Utrecht, Uppsalalaan 8,, 3584, CT Utrecht, The Netherlands.

Sanne Aarts (S)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99,, 3584, CG Utrecht, The Netherlands.
Department of Orthopaedics, University Medical Center Utrecht, Utrecht University, P.O. Box 85500,, 3508, GA Utrecht, The Netherlands.

Michael M Kaminski (MM)

University Medical Center Freiburg, Zentrale Klinische Forschung, Breisacher Straße 66,, 79106, Freiburg im Breisgau, Germany.

Soeren S Lienkamp (SS)

University Medical Center Freiburg, Zentrale Klinische Forschung, Breisacher Straße 66,, 79106, Freiburg im Breisgau, Germany.

Roman Pichler (R)

University Medical Center Freiburg, Zentrale Klinische Forschung, Breisacher Straße 66,, 79106, Freiburg im Breisgau, Germany.

Jos Malda (J)

Department of Orthopaedics, University Medical Center Utrecht, Utrecht University, P.O. Box 85500,, 3508, GA Utrecht, The Netherlands.
Regenerative Medicine Center Utrecht, Uppsalalaan 8,, 3584, CT Utrecht, The Netherlands.
Department of Equine Sciences, Room G05228, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100,, 3584, CX Utrecht, The Netherlands.

Tina Vermonden (T)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99,, 3584, CG Utrecht, The Netherlands.
Division of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99,, 3584, CG Utrecht, The Netherlands.
Regenerative Medicine Center Utrecht, Uppsalalaan 8,, 3584, CT Utrecht, The Netherlands.

Jitske Jansen (J)

Department of Pathology and Pediatric Nephrology, RIMLS, RIHS, Radboud University Medical Center, P.O. Box 9101, 6500, HB Nijmegen, The Netherlands.

Rosalinde Masereeuw (R)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99,, 3584, CG Utrecht, The Netherlands.
Regenerative Medicine Center Utrecht, Uppsalalaan 8,, 3584, CT Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH